Allarity Therapeutics Inc (ALLR)

Jul 27, 2026

Allarity Therapeutics, Inc. Revenue Breakdown – NASDAQ:ALLR - TradingView

Jul 27, 2026

Jul 27, 2026

Allarity Therapeutics Inc (ALLR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jul 27, 2026

Jul 27, 2026

Allarity Therapeutics Inc (ALLR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jul 27, 2026

Jul 27, 2026

Allarity Therapeutics Inc (ALLR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jul 27, 2026

Jul 26, 2026

Allarity Therapeutics Inc (ALLR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jul 26, 2026

Jul 26, 2026

ALLR|Allarity Therapeutics Inc|Price:1.190| - TradingKey

Jul 26, 2026

Jul 25, 2026

TradingKey - TradingKey

Jul 25, 2026

Jul 24, 2026

ALLR|Allarity Therapeutics Inc|Price:1.190|Chg%:-0.030 - TradingKey

Jul 24, 2026

Jul 23, 2026

Allarity Therapeutics, Inc. (ALLR) stock price, news, quote and history - Yahoo Finance UK

Jul 23, 2026

Jul 23, 2026

Allarity Therapeutics, Inc. (ALLR) Stock Price, News, Quote & History - Yahoo! Finance Canada

Jul 23, 2026

Jul 22, 2026

Allarity Therapeutics Inc (ALLR) News, Articles, Events & Latest Updates - Stocktwits

Jul 22, 2026

Jul 22, 2026

Are Medical Stocks Lagging Allarity Therapeutics, Inc. (ALLR) This Year? - Yahoo Finance Australia

Jul 22, 2026

Jul 17, 2026

Allarity Therapeutics (ALLR) Edges Higher as Stock Tests Narrow Trading RangeTRIN Signal - dars.gov.et

Jul 17, 2026

Jul 14, 2026

Allarity Therapeutics Q1 2026 Earnings: Narrower Loss Surpasses Expectations as Biotech Focuses on Pipeline ExecutionEstimate Accuracy - dars.gov.et

Jul 14, 2026

Jul 12, 2026

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Allarity Therapeutics - TMX Newsfile

Jul 12, 2026

Jul 12, 2026

Allarity Therapeutics (ALLR) Tests Support After 2.92% Decline – Key Levels Under ScrutinyMean Reversion Trade - dars.gov.et

Jul 12, 2026

Jul 10, 2026

Are medical stocks lagging Allarity Therapeutics, Inc. (ALLR) this year? - MSN

Jul 10, 2026

Jul 07, 2026

Allarity Therapeutics Obtains CLIA Certification For In-House DRP Testing And Advances Stenoparib Toward FDA Registration - marketscreener.com

Jul 07, 2026

Jul 07, 2026

Allarity Therapeutics obtains CLIA lab certification - Investing.com

Jul 07, 2026

Jul 07, 2026

Allarity Therapeutics Announces CLIA Certification, Clearing the Path for Advancing DRP® Testing for FDA Registration - Investing News Network

Jul 07, 2026

Jul 07, 2026

Allarity Therapeutics obtains CLIA lab certification By Investing.com - Investing.com Nigeria

Jul 07, 2026

Jul 07, 2026

Allarity’s Denmark lab gets CLIA status for U.S. cancer-trial testing - Stock Titan

Jul 07, 2026

Jul 07, 2026

ALLR Q1 2026 Earnings: Narrower-than-Expected Loss Fails to Offset Investor ConcernsAnalyst Earnings Estimate - DonanımHaber

Jul 07, 2026

Jul 06, 2026

Is Allarity Therapeutics, Inc. (ALLR) Stock Outpacing Its Medical Peers This Year? - NewsBreak: Local News & Alerts

Jul 06, 2026

Jul 03, 2026

Allarity Therapeutics Q1 2026 Earnings: Narrower-Than-Expected Loss as Pipeline Progress ContinuesSubscription Growth Report - dars.gov.et

Jul 03, 2026

Jul 01, 2026

Enterprise value to EBITDA forward of Allarity Therapeutics, Inc. – NASDAQ:ALLR - TradingView

Jul 01, 2026

Jul 01, 2026

Tranche Update on Allarity Therapeutics, Inc.'s Equity Buyback Plan announced on March 3, 2025. - marketscreener.com

Jul 01, 2026

Jul 01, 2026

Allarity Wins Key U.S. Patent for Stenoparib Diagnostic - TipRanks

Jul 01, 2026

Jul 01, 2026

Allarity Therapeutics (NASDAQ: ALLR) wins key DRP patent and secures shareholder backing - Stock Titan

Jul 01, 2026

Jun 30, 2026

Enterprise value to revenue forward of Allarity Therapeutics, Inc. – NASDAQ:ALLR - TradingView

Jun 30, 2026

Jun 30, 2026

Allarity receives U.S. patent for stenoparib diagnostic test - Investing.com

Jun 30, 2026

Jun 30, 2026

Allarity receives U.S. patent for stenoparib diagnostic test By Investing.com - Investing.com Nigeria

Jun 30, 2026

Jun 30, 2026

Allarity Therapeutics Announces the Grant of Essential U.S. Patent for Its Stenoparib DRP® Companion Diagnostic - Yahoo Finance

Jun 30, 2026

Jun 30, 2026

Price to earnings forward of Allarity Therapeutics, Inc. – NASDAQ:ALLR - TradingView

Jun 30, 2026

Jun 30, 2026

Price to book forward of Allarity Therapeutics, Inc. – NASDAQ:ALLR - TradingView

Jun 30, 2026

Jun 26, 2026

Allarity Therapeutics, Inc. Actuals & Estimates (NASDAQ:ALLR) - TradingView

Jun 26, 2026

Jun 26, 2026

ALLR Forecast — Price Target — Prediction for 2027 - TradingView

Jun 26, 2026

Jun 24, 2026

Is Allarity Therapeutics, Inc. (ALLR) outperforming other medical stocks this year? - MSN

Jun 24, 2026

Jun 23, 2026

Allarity Therapeutics Inc (ALLR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jun 23, 2026

Jun 22, 2026

12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga

Jun 22, 2026

Jun 22, 2026

Allarity Therapeutics Showcases Phase 2 Stenoparib Trial Progress in Advanced Ovarian Cancer at ESMO 2026 - Minichart

Jun 22, 2026

Jun 22, 2026

Form 8K Allarity Therapeutics Inc For: 22 June By Investing.com - Investing.com South Africa

Jun 22, 2026

Jun 22, 2026

Allarity Therapeutics (NASDAQ: ALLR) showcases Phase 2 stenoparib ovarian cancer trial - Stock Titan

Jun 22, 2026

Jun 19, 2026

Is Allarity Therapeutics, Inc. (ALLR) Outperforming Other Medical Stocks This Year? - Yahoo Finance

Jun 19, 2026

Jun 18, 2026

Allarity Therapeutics to Present Trial-in-Progress Poster on Phase 2 Stenoparib Trial at ESMO Gynaecological Cancers Congress 2026 - Investing News Network

Jun 18, 2026

Jun 18, 2026

Allarity to present trial poster at cancer congress - Investing.com

Jun 18, 2026

Jun 18, 2026

Allarity to present trial poster at cancer congress By Investing.com - Investing.com Canada

Jun 18, 2026

Jun 18, 2026

Allarity Therapeutics to Present Trial-in-Progress Poster - GlobeNewswire

Jun 18, 2026

Jun 18, 2026

Allarity Therapeutics Inc (ALLR) Institutional Confidence - TradingKey

Jun 18, 2026

Jun 18, 2026

Allarity Therapeutics Inc (ALLR) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jun 18, 2026

Jun 17, 2026

Allarity Therapeutics Inc (ALLR) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jun 17, 2026

Jun 17, 2026

Allarity Therapeutics Inc (ALLR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jun 17, 2026

Jun 11, 2026

Allarity Therapeutics Q1 2026 Earnings: EPS Beat by 24.24% Amid Ongoing Clinical DevelopmentRetail Earnings Report - Bölüm Sonu Canavarı

Jun 11, 2026